Kim, Se Hee
Shaw, Alexandra
Blackford, Robyn
Lowman, Wesley
Laux, Linda C.
Millichap, John J. http://orcid.org/0000-0002-0798-0131
Nordli, Douglas R. Jr.
Article History
Received: 12 October 2018
Accepted: 3 June 2019
First Online: 19 June 2019
Competing Interests
: The study did not receive any corporate sponsorship, government, or institutional funding. Alexandra Shaw, Wesley Lowman and Linda C. Laux reports no disclosures. Se Hee Kim serves as a member of the ILAE commission on Medical Therapies. She is a principal investigator for research grants from Yonsei University College of Medicine. Se Hee Kim received funding as a co-investigator in NIH/NINDS R12NS106921. Robyn Blackford has received consultant fees from Nutricia North America and serves on the advisory board of Trumacro, unrelated to this study. John J. Millichap serves as an Associate Editor of <i>Neurology</i>® and Editor of <i>Pediatric Neurology Briefs</i>; volunteers on the medical advisory board of and received research funding from the Jack Pribaz Foundation (KCNQ2.org); received royalties for online monographs from Up-To-Date; served on the scientific advisory board and speaker’s bureau for Mallinkrodt, Esai, Biomarin; served as a speaker for Sunovion and Nutricia North America; consulted for UCB, Xenon, Upsher-Smith, and Ionis; is principal investigator for a clinical trial funded by UCB Pharma; and is the principal investigator for research grants from Citizens United for Research in Epilepsy (CURE); and is the site investigator for research grants from Pediatric Epilepsy Research Foundation (PERF) and NIH (1-U01-NS090407). Douglas R. Nordli Jr. received funding as a co-investigator in NIH/NINDS 1-RO1-NS43209 and he is an associate editor for <i>UpToDate</i>.